Bloating in gastroparesis: severity, impact, and associated factors

scientific article

Bloating in gastroparesis: severity, impact, and associated factors is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043337563
P356DOI10.1038/AJG.2011.81
P8608Fatcat IDrelease_x3ay44wtx5gorpgt5iky5aohra
P932PMC publication ID3137717
P698PubMed publication ID21483459
P5875ResearchGate publication ID51042224

P2093author name stringFrank Hamilton
Kenneth L Koch
Gianrico Farrugia
Linda Lee
Thomas L Abell
William L Hasler
James Tonascia
Henry P Parkman
Pankaj J Pasricha
Aynur Unalp-Arida
NIDDK Gastroparesis Clinical Research Consortium (GpCRC)
Linda Nguyen
Laura A Wilson
William J Snape
P2860cites workA controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndromeQ24680181
Functional gastroduodenal disordersQ28238687
Origin of gas retention and symptoms in patients with bloatingQ33433044
Intestinal gas and bloating: effect of prokinetic stimulationQ33440815
Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndromeQ33441709
The utility of probiotics in the treatment of irritable bowel syndrome: a systematic reviewQ34016487
Abnormal intragastric distribution of food during gastric emptying in functional dyspepsia patientsQ34378245
Psychological dysfunction is associated with symptom severity but not disease etiology or degree of gastric retention in patients with gastroparesisQ34758912
Clinical Features of Idiopathic Gastroparesis Vary With Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis SeverityQ34946438
Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptyingQ35597269
Modulatory effects and afferent pathways of gastric electrical stimulation on rat thoracic spinal neurons receiving input from the stomachQ35757938
Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disordersQ35881311
Effect of a second-generation alpha2delta ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndromeQ35954087
Treatment of gastroparesis: a multidisciplinary clinical reviewQ36428532
Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndromeQ36808881
Prevalence and risk factors for abdominal bloating and visible distention: a population-based studyQ36969527
Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictorsQ37348163
Fat intolerance depends on rapid gastric emptyingQ41610783
Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptyingQ42717181
Small intestinal bacterial overgrowth in gastroparesis: are there any predictors?Q43212213
Bloating and distention in irritable bowel syndrome: the role of visceral sensationQ43360294
Predictors of delayed gastric emptying in diabetesQ43651899
Abdominal bloating in employed adults: prevalence, risk factors, and association with other bowel disordersQ44026090
Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL.Q47297864
Abnormal ghrelin and pancreatic polypeptide responses in gastroparesisQ48462562
Abdominal distention results from caudo-ventral redistribution of contents.Q50618892
Proximal gastric motor activity in response to a liquid meal in type I diabetes mellitus with autonomic neuropathy.Q51570823
Wide gastric antrum and low vagal tone in patients with diabetes mellitus type 1 compared to patients with functional dyspepsia and healthy individuals.Q51584025
Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia.Q51674445
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index.Q51947880
Predictors of gastroparesis in out-patients with secondary and idiopathic upper gastrointestinal symptomsQ57003811
Bloating and Distension in Irritable Bowel Syndrome: The Role of Gastrointestinal TransitQ60707831
Assessment of gastric emptying using a low fat meal: establishment of international control valuesQ73999675
Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patientsQ80109502
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectgastroparesisQ943897
P304page(s)1492-1502
P577publication date2011-04-12
P1433published inThe American Journal of GastroenterologyQ7713501
P1476titleBloating in gastroparesis: severity, impact, and associated factors
P478volume106

Reverse relations

cites work (P2860)
Q55234456A Critical Review of the Current Clinical Landscape of Gastroparesis.
Q37656120Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes
Q34412103Emerging drugs for the treatment of gastroparesis
Q38558515Exploration of the psychosocial issues associated with gastroparesis: a qualitative investigation
Q52382837Exploring Symptom Severity, Illness Perceptions, Coping Styles, and Well-Being in Gastroparesis Patients Using the Common Sense Model.
Q47145808Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews
Q39655063Gastric Enterovirus Infection: A Possible Causative Etiology of Gastroparesis
Q47775655Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms
Q58570237Gastroparesis
Q44629348Gastroparesis on the rise: incidence vs awareness?
Q90347934Gastroparesis: a turning point in understanding and treatment
Q26998965Gastroparesis: concepts, controversies, and challenges
Q37902510Gastroparesis: pathogenesis, diagnosis and management
Q84229759Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation
Q26823475Idiopathic gastroparesis
Q38110593Migraine and gastroparesis from a gastroenterologist's perspective
Q36328386Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis
Q34344032Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives
Q35691226Pathophysiology, evaluation, and treatment of bloating: hope, hype, or hot air?
Q37662652Psychological controversies in gastroparesis: A systematic review.
Q84862707Severity of dyspeptic symptoms correlates with delayed and early variables of gastric emptying
Q38321408Surgical treatment of medically refractory gastroparesis in the morbidly obese
Q37236392Utility of wireless motility capsule and lactulose breath testing in the evaluation of patients with chronic functional bloating
Q37204670What are the important subsets of gastroparesis?

Search more.